My guess is institutional investors will go after beaten-down tech and biotech stocks. More
It Doesn’t Pay to Pile Into Hedge-Fund Favorites
Hedge funds' holdings flood the news each quarter, but reports such as the Goldman Sachs VIP List aren't necessarily a good source of actionable trade ideas. More
3 Lofty Stocks That Are Set to Correct
We like these three stocks to continue outpacing the market for the rest of 2013 -- but they're also vulnerable to a big correction should the market take a spill. More
Richer 401ks: Great Trend, Great Lesson
The average 401k balance now stands at more than $80,000 -- a nice uptick from last year and worlds apart from their 2013 low. But how we got there is important, too. More
The Cold, Hard Facts Behind Funding Your Retirement
It's getting much harder to fund a "safe" retirement, and investors need to understand some of the basic moves they should take. Here are some tips to that end More
What’s Your Exit Strategy?
With the markets heading ever higher now is a very good time to review your portfolio and determine a strategy to maximize gains before any pullback More
12 “Triple F” Stocks to Sell
This week, 12 stocks get F's ("strong strong") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade. More
